Nine Masts Capital’s Gossamer Bio GOSS Stock Holding History

Nine Masts Capital’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-114,766	Closed	-$37.7K	–	224
2026 Q1	$37.7K	Buy	+114,766	New	+$180K	0.01%	190

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Nine Masts Capital's GOSS Position: Q2 2026 in Review

Nine Masts Capital sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 114,766 shares — an estimated $37.7K sold.

Nine Masts Capital first reported a position in GOSS in Q1 2026 and held it in 1 quarter. The position peaked at $37.7K in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Nine Masts Capital reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
Nine Masts Capital sold 114,766 Gossamer Bio shares in Q2 2026, an estimated $37.7K.
Nine Masts Capital first reported a position in Gossamer Bio in Q1 2026 and held it in 1 quarter.
Nine Masts Capital's Gossamer Bio position peaked at $37.7K in Q1 2026.
170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.